Holen Sie sich die Stockscreener-App
3.48
2.96%
0.10
Schlusskurs vom Vortag:
$3.38
Offen:
$3.35
24-Stunden-Volumen:
804.26K
Relative Volume:
0.87
Marktkapitalisierung:
$258.44M
Einnahmen:
$6.96M
Nettoeinkommen (Verlust:
$-46.51M
KGV:
-20.28
EPS:
-0.1716
Netto-Cashflow:
$-37.99M
1W Leistung:
+0.58%
1M Leistung:
-12.56%
6M Leistung:
+30.83%
1J Leistung:
-78.03%
1-Tages-Spanne:
$3.27
$3.49
1-Wochen-Bereich:
$3.22
$3.49
52-Wochen-Spanne:
$1.60
$16.02
Perspective Therapeutics Inc Stock (CATX) Company Profile
Firmenname
Perspective Therapeutics Inc
Sektor
Branche
Telefon
509-375-1202
Adresse
350 Hills Street, Suite 106, Richland
Vergleichen Sie CATX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CATX
Perspective Therapeutics Inc
|
3.48 | 239.87M | 6.96M | -46.51M | -37.99M | -0.1716 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-11-25 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-01 | Eingeleitet | Wedbush | Outperform |
| 2024-09-25 | Eingeleitet | Truist | Buy |
| 2024-07-25 | Eingeleitet | BofA Securities | Buy |
| 2024-05-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten
Visual analytics tools that track Perspective Therapeutics Inc. performanceJuly 2025 Analyst Calls & Verified Momentum Stock Ideas - Newser
Published on: 2025-09-12 19:03:34 - Newser
Historical volatility pattern of Perspective Therapeutics Inc. visualizedJuly 2025 Earnings & Low Risk Entry Point Guides - Newser
Regression analysis insights on Perspective Therapeutics Inc. performance2025 Earnings Impact & AI Enhanced Trading Signals - Newser
Published on: 2025-09-12 17:12:08 - Newser
How hedge fund analytics apply to Perspective Therapeutics Inc. stockQuarterly Investment Review & Fast Moving Trade Plans - Newser
Perspective Therapeutics Inc. stock trend outlook and recovery pathWeekly Stock Summary & Consistent Profit Trade Alerts - Newser
Is a relief rally coming for Perspective Therapeutics Inc. holdersWeekly Risk Report & AI Powered Trade Plan Recommendations - Newser
Is Perspective Therapeutics Inc. reversing from oversold territoryBear Alert & Momentum Based Trading Ideas - Newser
Published on: 2025-09-12 03:50:21 - Newser
Analyzing net buyer seller activity in Perspective Therapeutics Inc.Trade Performance Summary & AI Powered Buy/Sell Recommendations - Newser
How to interpret RSI for Perspective Therapeutics Inc. stockJuly 2025 Movers & AI Based Buy and Sell Signals - Newser
Walleye Capital LLC Sells 436,402 Shares of Perspective Therapeutics, Inc. $CATX - MarketBeat
What institutional flow reveals about Perspective Therapeutics Inc.2025 Buyback Activity & Expert Verified Stock Movement Alerts - Newser
Published on: 2025-09-11 23:13:11 - Newser
Technical signs of recovery in Perspective Therapeutics Inc.July 2025 Levels & Weekly Return Optimization Alerts - Newser
Custom strategy builders for tracking Perspective Therapeutics Inc.Market Movement Recap & Long Hold Capital Preservation Plans - Newser
Perspective Therapeutics Inc.’s volatility index tracking explainedTrade Entry Report & Fast Exit and Entry Strategy Plans - Newser
Strategies to average down on Perspective Therapeutics Inc.July 2025 EndofMonth & Reliable Price Breakout Alerts - Newser
Published on: 2025-09-11 04:19:03 - Newser
B.Riley Financial Maintains Perspective Therapeutics(CATX.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
Volume spikes in Perspective Therapeutics Inc. stock – what they meanMarket Volume Report & High Win Rate Trade Tips - Newser
What is B. Riley's Forecast for CATX Q3 Earnings? - MarketBeat
Chart based analysis of Perspective Therapeutics Inc. trends2025 Trading Recap & AI Forecasted Entry/Exit Points - Newser
What does recent volatility data suggest for Perspective Therapeutics Inc.2025 Performance Recap & Reliable Volume Spike Trade Alerts - Newser
Measuring Perspective Therapeutics Inc.’s beta against major indicesTrade Entry Summary & Precise Buy Zone Identification - Newser
What technical models suggest about Perspective Therapeutics Inc.’s comebackForecast Cut & Free Weekly Chart Analysis and Trade Guides - Newser
Can Perspective Therapeutics Inc. lead its sector in growthQuarterly Profit Summary & Reliable Breakout Forecasts - 뉴스영
Is Perspective Therapeutics Inc. Forming a Consolidation Base2025 Pullback Review & Free Daily Entry Point Trade Alerts - beatles.ru
Is Perspective Therapeutics Inc. stock entering bullish territoryJuly 2025 Intraday Action & Daily Profit Focused Screening - Newser
Does Perspective Therapeutics Inc. stock reflect fundamentals2025 Support & Resistance & Accurate Intraday Trade Tips - beatles.ru
Published on: 2025-09-07 23:03:44 - beatles.ru
B. Riley Research Analysts Lower Earnings Estimates for CATX - Defense World
Chart overlay techniques for tracking Perspective Therapeutics Inc.July 2025 Closing Moves & Fast Gain Stock Trading Tips - Newser
Leading vs lagging indicators on Perspective Therapeutics Inc. performanceJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - Newser
How to use a screener to detect Perspective Therapeutics Inc. breakoutsJuly 2025 Summary & Real-Time Volume Analysis Alerts - Newser
Risk vs reward if holding onto Perspective Therapeutics Inc.Trade Performance Summary & Precise Buy Zone Tips - Newser
Perspective Therapeutics, Inc. (NYSE:CATX) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Can volume confirm reversal in Perspective Therapeutics Inc.2025 Major Catalysts & Pattern Based Trade Signal System - Newser
What indicators show strength in Perspective Therapeutics Inc.2025 EndofYear Setup & Safe Capital Investment Plans - Newser
Applying chart zones and confluence areas to Perspective Therapeutics Inc.July 2025 Analyst Calls & Community Verified Swing Trade Signals - Newser
Perspective Therapeutics Announces Chief Financial Officer Changes - MarketScreener
Perspective Therapeutics Names Joel Sendek as CFO - MarketScreener
Perspective Therapeutics Appoints Maya Martinez-Davis to Board - The Globe and Mail
Perspective Therapeutics Appoints Joel Sendek as CFO - TipRanks
Perspective Therapeutics' Strategic Leadership Shift: How CFO Joel Sendek Could Ignite Financial and Operational Momentum - AInvest
Perspective Therapeutics' Strategic Leadership Move and Its Implications for Biotech Growth - AInvest
Perspective Therapeutics Appoints Biotech Veteran Joel Sendek as Chief Financial Officer - GlobeNewswire
Former Wall Street All-Star Who Raised $2.5B: Perspective Therapeutics Lands Biotech Finance Veteran as CFO - Stock Titan
Smart tools for monitoring Perspective Therapeutics Inc.’s price actionEntry Point & Long-Term Safe Return Strategies - Newser
Aug EndMonth: Can Perspective Therapeutics Inc. deliver alphaJuly 2025 Trade Ideas & High Accuracy Investment Entry Signals - khodrobank.com
Finanzdaten der Perspective Therapeutics Inc-Aktie (CATX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.14%
1.01%
Kapitalisierung:
|
Volumen (24h):